Shibata Y, Nakata K, Tsuruta S, Hamasaki K, Hayashida Y, Kato Y, Nakao K, Eguchi K
The First Department of Internal Medicine, Nagasaki University School of Medicine, Nagasaki, Japan.
Int J Oncol. 1999 Jun;14(6):1153-6. doi: 10.3892/ijo.14.6.1153.
The risk of hepatocellular carcinoma (HCC) in patients chronically infected by hepatitis C virus (HCV) is relatively higher in Japan than in Western countries. The presence of hepatitis B virus X (HBX)-DNA in the liver tissue samples obtained on enrollment from 69 patients with HCV-associated cirrhosis who were subsequently followed in our hospital was analyzed by polymerase chain reaction (PCR). During the follow-up period of 5.7+/-3.2 years (mean +/- SD), 52 (75%) of 69 patients developed HCC. The PCR analysis indicated that the HBX-DNA sequence was detected in 25 (48%) of 52 patients who developed HCC during follow-up, but in only 3 (18%) of 17 patients who did not (P<0.05). These results suggest that HBX, a hepatitis B viral product relevant to hepatocarcinogenesis, is involved in development of HCC in some patients chronically infected by HCV in Japan.
在日本,丙型肝炎病毒(HCV)慢性感染患者发生肝细胞癌(HCC)的风险相对高于西方国家。我们对69例HCV相关性肝硬化患者入组时采集的肝组织样本进行了聚合酶链反应(PCR)分析,检测其中乙型肝炎病毒X(HBX)-DNA的存在情况,这些患者随后在我院接受随访。在5.7±3.2年(均值±标准差)的随访期内,69例患者中有52例(75%)发生了HCC。PCR分析表明,在随访期间发生HCC的52例患者中,有25例(48%)检测到HBX-DNA序列,而在未发生HCC的17例患者中,只有3例(18%)检测到(P<0.05)。这些结果表明,HBX是一种与肝癌发生相关的乙肝病毒产物,在日本一些HCV慢性感染患者的HCC发生过程中发挥作用。